Exelixis Inc (EXEL)
34.83
+0.18
(+0.52%)
USD |
NASDAQ |
Nov 21, 16:00
34.82
0.00 (0.00%)
After-Hours: 20:00
Exelixis Market Cap: 9.947B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 9.947B |
| November 20, 2024 | 9.895B |
| November 19, 2024 | 9.827B |
| November 18, 2024 | 9.858B |
| November 15, 2024 | 9.838B |
| November 14, 2024 | 10.01B |
| November 13, 2024 | 10.05B |
| November 12, 2024 | 10.24B |
| November 11, 2024 | 10.34B |
| November 08, 2024 | 10.35B |
| November 07, 2024 | 10.22B |
| November 06, 2024 | 10.14B |
| November 05, 2024 | 9.930B |
| November 04, 2024 | 9.793B |
| November 01, 2024 | 9.744B |
| October 31, 2024 | 9.481B |
| October 30, 2024 | 9.264B |
| October 29, 2024 | 8.205B |
| October 28, 2024 | 8.139B |
| October 25, 2024 | 7.959B |
| October 24, 2024 | 8.028B |
| October 23, 2024 | 8.088B |
| October 22, 2024 | 8.233B |
| October 21, 2024 | 8.185B |
| October 18, 2024 | 8.259B |
| Date | Value |
|---|---|
| October 17, 2024 | 8.305B |
| October 16, 2024 | 8.388B |
| October 15, 2024 | 8.145B |
| October 14, 2024 | 7.499B |
| October 11, 2024 | 7.496B |
| October 10, 2024 | 7.347B |
| October 09, 2024 | 7.267B |
| October 08, 2024 | 7.256B |
| October 07, 2024 | 7.519B |
| October 04, 2024 | 7.619B |
| October 03, 2024 | 7.499B |
| October 02, 2024 | 7.573B |
| October 01, 2024 | 7.516B |
| September 30, 2024 | 7.416B |
| September 27, 2024 | 7.405B |
| September 26, 2024 | 7.485B |
| September 25, 2024 | 7.434B |
| September 24, 2024 | 7.496B |
| September 23, 2024 | 7.519B |
| September 20, 2024 | 7.536B |
| September 19, 2024 | 7.653B |
| September 18, 2024 | 7.650B |
| September 17, 2024 | 7.873B |
| September 16, 2024 | 7.836B |
| September 13, 2024 | 7.548B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.417B
Minimum
Mar 16 2020
10.35B
Maximum
Nov 08 2024
6.500B
Average
6.484B
Median
Market Cap Benchmarks
| Merck & Co Inc | 252.61B |
| ADMA Biologics Inc | 5.035B |
| Vericel Corp | 2.799B |
| Catalyst Pharmaceuticals Inc | 2.519B |
| Inovio Pharmaceuticals Inc | 105.97M |
Market Cap Related Metrics
| PE Ratio | 22.33 |
| PS Ratio | 5.036 |
| PEG Ratio | 0.0495 |
| Price to Book Value | 4.371 |
| Price to Free Cash Flow | 25.89 |
| Price | 34.83 |
| Earnings Yield | 4.48% |
| PEGY Ratio | 0.0495 |
| Operating PE Ratio | 17.24 |
| Normalized PE Ratio | 19.59 |